David Hofer, Managing Director
Selling and Buying in the Hottest Cannabis Markets
Now that the DEA has made Rescheduling official, we want to keep you informed of the most interesting industry events and our prime listings in the most sought-after markets.
In New Jersey, for example, cannabis sales reached the $1 Billion sales mark last year.
Here’s a chance for you to learn more about investment potential in New Jersey:
Join us at the Benzinga Market Spotlight New Jersey-Cannabis on Monday, June 17, in New Brunswick, for potentially profitable insights on the future of cannabis in New Jersey. AND take 20% off your registration by using the Promo Code: “Highway20” at the link below…
https://www.eventbrite.com/e/871406729987/?discount=HIGHWAY20
WE’VE GOT NEW JERSEY COVERED for YOU – over 29 prime listings.
Here is a sampling…
Dispensaries in the Largest NJ Markets
Newark – High traffic Dispensary with sales of $6M.
Jersey City – 3 Dispensaries, 2 fully licensed and in profitable operation, 1 with approved site.
Camden – Thriving downtown Dispensary, one of 10- store city cap, with $3.6M annual revenue run rate. Will ramp to $6M+.
Montclair – (Under Contract)
Ft. Lee – Cap to 2 Dispensaries in the city. We have the second. The existing Dispensary is doing $5M+/yr
And, prime Dispensaries in Vernon, Red Bank, Voorhees, and Ocean County
Locations Approved for Dispensary Licenses:
Franklin Township – 3.4K sf in larger building with high traffic shops, 56 parking spaces, local approval for Dispensary License, favorable lease terms.
Secaucus – In vicinity of Meadowlands Sports Complex, 4K sf in larger building with 43 parking spaces, local approval for Dispensary License, favorable lease terms.
Highland Park – Near Rutgers University New Brunswick campus, in larger building with 50+ parking spaces, local approval for Dispensary License, favorable lease terms.
OHIO:
- Just Became Available
- Level II Grow with Processing
- Akron-Area Dispensary (Under Contract)
- Gross Revenue Run Rate at $5M/year and climbing, approx. 5K s.f. with ample parking, lease with purchase option.
- Toledo (Under Contract)
- Large operating Medical Dispensary for purchase or lease. Qualifies for Adult Use License in June at No Charge.
- Oxford (Under Contract)
- Large operating Medical Dispensary for purchase or lease.
- Centrally Located Processing Facility
- High capacity 12K s.f. Processing Facility, Central Ohio, extensive medical cannabis and white labeling experience. OMMCP certified, FDA compliant.
HIGHWAY 33 CAPITAL is BUYING in OHIO:
- 10(B) Dispensary License
- Level II & Level I Cultivations
- Processing
- Well-located Dispensaries
FLORIDA – License Opportunity (Under Contract)
We represent the most promising contender – a recognized leader in cannabis legislation and financing in the state with a team that received top scores in the last 2 rounds of licensing applications, including the winning application in the most recent round.
Please let me know when you would like more information about any of these opportunities. And, let me know when you would like to discuss any of this by meeting up at the NJ Spotlight.
Thank you, David
Get the Highway EDGE on vital markets for your portfolio.
Highway 33 is a capital advisory firm capable of handling global transactions. We thrive in fiercely competitive and highly regulated industries. Including but not limited to: pharma, biotech, healthcare, cannabis, CBD/hemp and ancillary technology companies. highway 33 capital advisory
highway 33 capital advisory
highway 33 capital advisory
Technology
In IT, SaaS companies are projected to generate $287.3 billions in revenue next year. There is a very powerful reason that has special significance for investors – since with over 80% of all enterprise workloads now shifted to the cloud. It won’t be long before companies are running solely on SaaS.
Well-structured capital requires a solid foundation.
Highway 33 is a boutique capital advisory firm that specializes in structuring mergers and acquisitions as well as debt and equity fundraising transactions. Our skill set is unique. Our industry-domain experience is deep. We specialize in preparing and introducing well-vetted Investment opportunities to a network of high net-worth individuals, family offices, private equity firms, venture capitalists and specialty-focused funds.
We specialize. Structure capital.
And vet, vet, vet.
We excel in highly regulated industries. Structuring capital needs for clients in pharma, biotech, healthcare, cannabis, CBD/hemp and ancillary technologies. We drive growth and enterprise valuations for our clients through M&A, non-dilutive debt financing and/or capital investments ranging from $5M to $100M+. Since our industries of specialization are known for volatility and risk, we serve companies who have established clear market-leadership potential. And have “passed” our thorough vetting process.
For solutions that come from everywhere, start here.
Because we’re independent, we can offer unbiased strategic direction, delivered by a uniquely skilled team. Our areas of expertise cover virtually every aspect of business and industry – investment, operations, legal and public policy, engineering, finance, research, even marketing. And all of our experience is available, at a moment’s notice, to help you define and attain your investment objectives in the industries we know best – including the new frontier of the cannabis marketplace.
We exist to structure and secure capital.
For innovative industries.
Highway 33 Capital Advisory team provides the consultation and capital-structure services to build leadership brands in the biotech, pharmaceutical, health tech and cannabis industries, including in legal medical and adult-use recreational markets. Our services include the acquisition of growth and expansion capital, M&A transactions, product licensing and distribution agreements.
We know canna. We know capital.
Introducing our new Canna Debt Fund. Canna needs capital. Lack thereof is the biggest stumbling block to incredible growth since government regs. The Fund’s target return is 9.65% annually to investors. Our primary market focus is cannabis, hemp/CBD, biomass purchases for extractors, and financing commercial real estate, equipment and short-term working capital needs of licensed growers, extractors and retailers. Interested?
Industry insights to give you an edge.
Trends. Who’s investing where. Why. And what’s next. Keep up to date with changing times and changing markets. Be ahead of the curve. Get the Edge by subscribing to our weekly newsletter featuring industry viewpoints and unique investment opportunities: